as a promising anti-obesity treatment in knockout mice.

Introduction: The therapeutic effects and mechanisms of () extracts have been examined concerning inflammation, photoaging, and gastritis; however, their effect on obesity is still being investigated.

Methods: We administered a methanol extract of (MED) orally to knockout (KO) mice for 4 weeks to investigate the therapeutic effects on obesity, weight gain, fat accumulation, lipid metabolism, inflammatory response, and β-oxidation.

Results: In KO mice, MED significantly reduced weight gains, food intake, and total cholesterol and glyceride levels. Similar reductions in fat weights and adipocyte sizes were also observed. Furthermore, MED treatment reduced liver weight, lipid droplet numbers, the expressions of adipogenesis and lipogenesis-related genes, and the expressions of lipolysis regulators in liver tissues. Moreover, the iNOS-mediated COX-2 induction pathway, the inflammasome pathway, and inflammatory cytokine levels were reduced, but β-oxidation was increased, in the livers of MED-treated KO mice.

Conclusion: The results of this study suggest that MED ameliorates obesity and has considerable potential as an anti-obesity treatment.